ArticleOncoimmunology

Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients.

Philippe Lefrançois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.